Published in Infect Immun on February 01, 1977
Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J Cell Biol (1980) 1.52
Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors. Immunology (1979) 1.42
Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. Immunology (1983) 1.20
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. Immunology (1979) 1.16
A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration. Immunology (1980) 1.10
Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation. J Clin Invest (1981) 1.03
Identification of a human neutrophil angiotension II-generating protease as cathepsin G. J Clin Invest (1982) 0.96
Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. J Clin Invest (1991) 0.91
Studies on the kinetic properties and subcellular localization of adenine nucleotide phosphatases in peripheral blood lymphocytes from control subjects and patients with common variable primary hypogammaglobulinaemia. Clin Exp Immunol (1982) 0.86
Calcium ion-dependent adenosine triphosphatase activity and plasma-membrane phosphorylation in the human neutrophil. Biochem J (1979) 0.83
Chemotactic factor receptor modulation and cytoskeletal structures. Infect Immun (1981) 0.82
Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN). Immunology (1979) 0.82
Allosteric transformation of reduced nicotinamide adenine dinucleotide (phosphate) oxidase induced by phagocytosis in human polymorphonuclear leukocytes. Infect Immun (1978) 0.81
Subcellular localization of NAD(P)H oxidase(s) in human neutrophilic polymorphonuclear leucocytes. Biochem J (1978) 0.80
Preparation of secretory vesicle-free plasma membranes by isopycnic sucrose gradient fractionation of neutrophils purified by the gelatin method. Cytotechnology (2005) 0.75
Polymorphonuclear leukocytic sialic acid and sialidase activity in obesity. Indian J Clin Biochem (1997) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Leukocyte preparations from human blood: evaluation of their morphologic and metabolic state. J Lab Clin Med (1962) 4.25
Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest (1974) 4.09
Plasma membranes of mammalian cells: a review of methods for their characterization and isolation. J Cell Biol (1973) 2.99
Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. I. Evidence for an ecto-adenosine monophosphatase, adenosine triphosphatase, and -p-nitrophenyl phosphates. J Biol Chem (1974) 2.65
"Tuftsin": a natural phagocytosis stimulating peptide. Nature (1970) 1.88
Metabolism of the circulating leukocyte. Physiol Rev (1965) 1.76
An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest (1975) 1.63
Characterization of "ecto-ATPase" of human blood platelets. Arch Biochem Biophys (1967) 1.55
Ecto-enzyme of granulocytes: 5'-nucleotidase. Science (1974) 1.46
Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. II. Properties and suitability as markers for the plasma membrane. J Biol Chem (1974) 1.38
Absence of the membrane marker enzyme 5'-nucleotidase in human polymorphonuclear leukocytes. Biochem Med (1976) 1.14
Purification of plasma membrane from BCG-induced rabbit alveolar macrophages. J Reticuloendothel Soc (1976) 0.98
Letter: Activity of 5'nucleotidase in polymorphonuclear leukocytes. Blood (1975) 0.92
Drug inhibitable ecta-ATPase in leukocytes. Life Sci (1975) 0.81
Increased adenosine triphosphatase in leukocytes of asthmatic children. J Clin Invest (1974) 0.81
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17
Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol (1982) 3.11
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
A modified procedure for the determination of leukocyte alkaline phosphatase. Biochem Med (1970) 2.35
Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol (1971) 2.01
Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00
New biological activity following intravascular activation of the complement cascade. Nature (1974) 1.89
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem (2000) 1.78
Selectins: a family of adhesion receptors. Cell (1991) 1.72
Structural characterization of a higher plant calmodulin : spinacia oleracea. Plant Physiol (1984) 1.69
Spinach calmodulin: isolation, characterization, and comparison with vertebrate calmodulins. Biochemistry (1980) 1.66
Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte. Infect Immun (1971) 1.64
An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest (1975) 1.63
Release and metabolism of arachidonic acid in human neutrophils. J Biol Chem (1981) 1.62
Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol (1981) 1.56
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53
Initiation of the respiratory burst in human polymorphonuclear neutrophils: a critical review. J Reticuloendothel Soc (1978) 1.52
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med (1994) 1.47
Oxidative metabolism of the human eosinophil. Blood (1977) 1.45
Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol (1986) 1.45
Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest (1980) 1.44
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem (1989) 1.42
Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest (1976) 1.41
Functional characteristics of human toxic neutrophils. J Infect Dis (1971) 1.41
Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. J Biol Chem (1982) 1.39
Endoscopic drainage of pancreatic pseudocysts. Gastrointest Endosc (1985) 1.38
Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke (2001) 1.30
Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes. J Immunol (1978) 1.27
Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem (1992) 1.26
Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events. J Clin Invest (1979) 1.26
Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun (1992) 1.25
Isolation and characterization of calmodulin from spinach leaves and in vitro translation mixtures. Proc Natl Acad Sci U S A (1980) 1.25
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay. J Clin Invest (1977) 1.22
Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes. Infect Immun (1974) 1.22
Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes. Clin Immunol Immunopathol (1988) 1.20
The effects of ascorbic acid on bactericidal mechanisms of neutrophils. J Infect Dis (1971) 1.19
Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest (1990) 1.19
Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J Biol Chem (1999) 1.18
Efficiency of cultures of rectal swabs and faecal specimens in detecting salmonella carriers: correlation with numbers of salmonellas excreted. J Hyg (Lond) (1966) 1.18
Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C. J Biol Chem (1987) 1.17
Effect of cyanide on NADPH oxidation by granules from human polymorphonuclear leukocytes. Blood (1977) 1.17
Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease. J Clin Invest (1988) 1.16
Oxidative bactericidal mechanisms of polymorphonuclear leukocytes. J Infect Dis (1975) 1.15
Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues. J Immunol (1981) 1.15
Absence of the membrane marker enzyme 5'-nucleotidase in human polymorphonuclear leukocytes. Biochem Med (1976) 1.14
Reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate diaphorase activity in human polymorphonuclear leukocytes. Infect Immun (1974) 1.12
Anaphylactic actions of platelet-activating factor. Am J Pathol (1981) 1.12
Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung. Am J Pathol (1980) 1.11
Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. Am J Pathol (1981) 1.11
Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol (1991) 1.11
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol (1994) 1.10
Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J Clin Invest (1991) 1.10
Stimulation of the hexose monophosphate shunt in human neutrophils by ascorbic acid: mechanism of action. Antimicrob Agents Chemother (1972) 1.08
Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C. J Biol Chem (1992) 1.08
Tumor necrosis factor alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation. J Biol Chem (1991) 1.07
Rapid separation and quantitation of 3',5'-cyclic nucleotides and 5'-nucleotides in phosphodiesterase reaction mixtures using high-performance liquid chromatography. J Biochem Biophys Methods (1980) 1.07
Antacids vs placebos in peptic ulcer therapy. A controlled double-blind investigation. JAMA (1973) 1.05
Human eosinophilic peroxidase: biochemical characterization. Biochem Med (1978) 1.05
Nitroblue tetrazolium reduction. False positive and false negative results. Blood (1973) 1.05
Deficiency of NADPH oxidase activity in chronic granulomatous disease. J Pediatr (1977) 1.05
Chemiluminescence of human neutrophils induced by soluble stimuli: effect of divalent cations. Infect Immun (1982) 1.05
Phagocytosis-induced release of arachidonic acid from human neutrophils. Biochem Biophys Res Commun (1979) 1.04
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections. Antimicrob Agents Chemother (1983) 1.04
Human toxic neutrophils. 3. Metabolic characteristics. J Infect Dis (1973) 1.03
Evaluation of chronic granulomatous disease by a chemiluminescence assay of microliter quantities of whole blood. Clin Chem (1981) 1.02
Stimulation of oxidative metabolism in polymorphonuclear leukocytes by catecholamines. J Reticuloendothel Soc (1972) 1.02
Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. Am J Pathol (1981) 1.02
An interstate outbreak of salmonellosis traced to a contaminated food supplement. Am J Epidemiol (1966) 1.01
Functional and metabolic studies of polymorphonuclear leukocytes in the congenital Pelger-Huet anomaly. Blood (1980) 1.01
Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. J Immunol (1987) 1.01
The generation of superoxide anion by various types of phagocyte. J Infect Dis (1975) 1.01
Streptococcus pneumoniae-stimulated macrophages induce neutrophils to emigrate by a CD18-independent mechanism of adherence. Circ Shock (1990) 1.00
Enhancement of hexose uptake in human polymorphonuclear leukocytes by activated complement component C5a. Proc Natl Acad Sci U S A (1979) 1.00
The in vitro effect of steroids on polymorphonuclear leukocyte metabolism. Proc Soc Exp Biol Med (1972) 1.00